Showing results (171-180 of 206) with videos related to
Sort By:
Pageof 21
Journal of the American Society of Hypertension : JASH|April 15, 2014
Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart diseaseMichael J Burla, Aaron M Brody, Brian A Ference, et al.Clinical Therapeutics|September 18, 2001
Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertensionJ M Flack, E Saunders, A Gradman, et al.American Journal of Hypertension|November 1, 1994
Urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in mild hypertensionP A Abraham, S R Mascioli, C A Launer, et al.Lancet (London, England)|November 10, 2022
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trialMarkus P Schlaich, Marc Bellet, Michael A Weber, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2021
Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophyCesar A Romero, Shobi Mathew, Benjamin Wasinski, et al.The American Journal of the Medical Sciences|April 1, 1997
Hypertension-related morbidity and mortality in the southeastern United StatesW D Hall, C M Ferrario, M A Moore, et al.Ethnicity & Disease|November 8, 2007
Advancing the science of health disparities researchNancy T Artinian, Richard B Warnecke, Kimberly M Kelly, et al.American Journal of Hypertension|July 5, 2020
Effect of Lower Blood Pressure Goals on Left Ventricular Structure and Function in Patients With Subclinical Hypertensive Heart DiseasePhillip D Levy, Michael J Burla, Michael J Twiner, et al.The New England Journal of Medicine|September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant HypertensionJohn M Flack, Michel Azizi, Jenifer M Brown, et al.Hypertension (Dallas, Tex. : 1979)|January 22, 2025
Aprocitentan for Blood Pressure Reduction in Black PatientsJohn M Flack, Markus P Schlaich, Michael A Weber, et al.Pageof 21